HER-2 Expression in Immunohistochemistry Has No Prognostic Significance in Gastric Cancer Patients
Figure 2
Kaplan-Meier curves for survival and expression of HER-2 in studied group of 78 gastric cancer patients: No correlation was observed between Hercep test score () (a), percentage of HER-2 positive gastric cancer cells () (b), intensity of immunohistochemical reaction () (c) and IRS rate () (d).